Cargando…

Developing a nanoparticle test for prostate cancer scoring

BACKGROUND: Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Qun, Litherland, Sally A, Sullivan, Shannon, Hallquist, Hillari, Decker, David A, Rivera-Ramirez, Inoel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337274/ https://www.ncbi.nlm.nih.gov/pubmed/22404986 http://dx.doi.org/10.1186/1479-5876-10-44

Ejemplares similares

Ureterolysis with ureterotomy and omental sleeve wrap in patients with radiation induced pelvic retroperitoneal fibrosis
por: Neulander, Endre Zoltan, et al.
Publicado: (2019)

Blatchford Score Is Superior to AIMS65 Score in Predicting the Need for Clinical Interventions in Elderly Patients with Nonvariceal Upper Gastrointestinal Bleed
por: Abusaada, Khalid, et al.
Publicado: (2016)

Immunopathogenic Interaction of Environmental Triggers and Genetic Susceptibility in Diabetes: Is Epigenetics the Missing Link?
por: Litherland, Sally A.
Publicado: (2008)

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery
por: Lee, Bongyong, et al.
Publicado: (2020)

Illicit drug use and male barroom aggression among members of the Australian construction industry: Associations with personality and masculinity factors
por: Litherland, Steven, et al.
Publicado: (2022)

Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
por: Katzendorn, Olga, et al.
Publicado: (2022)

A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection
por: Zheng, Tianyu, et al.
Publicado: (2020)

Hormone replacement therapy (HRT) and its effect on mammographic specificity and sensitivity
por: Litherland, JC
Publicado: (2002)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis
por: Bahlool, Ahmad Z., et al.
Publicado: (2022)

Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa
por: Kim, Michelle S., et al.
Publicado: (2022)

Development and testing of a stifle function score in dogs
por: Gundersen, Katie, et al.
Publicado: (2022)

Chitosan Nanoparticles in Atherosclerosis—Development to Preclinical Testing
por: Sriamornsak, Pornsak, et al.
Publicado: (2022)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
por: Tosoian, Jeffrey J., et al.
Publicado: (2022)

Development and validation of a polygenic hazard score for aggressive prostate cancer identification
por: Mohamed, Nihal E., et al.
Publicado: (2019)

A high COPD assessment test score may predict anxiety in COPD
por: Harryanto, Hilman, et al.
Publicado: (2018)

Effect of obesity on International Prostate Symptom Score and prostate volume
por: Yelsel, Kazım, et al.
Publicado: (2015)

Prostate Cancer Postoperative Nomogram Scores and Obesity
por: Major, Jacqueline M., et al.
Publicado: (2011)

Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer
por: McDunn, Jonathan E., et al.
Publicado: (2015)

Development and initial testing of a Health Confidence Score (HCS)
por: Benson, Tim, et al.
Publicado: (2019)

Multiparametric Magnetic Resonance Imaging-based Prostate Specific Antigen Density and PI-RADSv2 score help identify Apical Prostate Cancer
por: Huang, Cong, et al.
Publicado: (2023)

4.3: Upgrades of B5a (non-invasive) core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme
por: Sim, YT, et al.
Publicado: (2013)

Can new, improvised Visual Prostate Symptom Score replace the International Prostate Symptom Score? Indian perspective
por: Sanman, K. N, et al.
Publicado: (2020)

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
por: Seibert, Tyler M, et al.
Publicado: (2018)

Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer
por: Decker, Brennan, et al.
Publicado: (2014)

Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer
por: Nagpal, Kunal, et al.
Publicado: (2019)

The Development of a Gleason Score-Related Gene Signature for Predicting the Prognosis of Prostate Cancer
por: Yimamu, Yiliyasi, et al.
Publicado: (2022)

Z Scores, Standard Scores, and Composite Test Scores Explained
por: Andrade, Chittaranjan
Publicado: (2021)

Prospective comparison of the novel visual prostate symptom score (VPSS) versus the international prostate symptom score (IPSS), and assessment of patient pain perception with regard to transrectal ultrasound guided prostate biopsy
por: Els, M., et al.
Publicado: (2019)

The Contribution of Network Organization and Integration to the Development of Cognitive Control
por: Marek, Scott, et al.
Publicado: (2015)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

Correlation Between the Visual Prostate Symptom Score and International Prostate Symptom Score in Patients With Lower Urinary Tract Symptoms
por: Park, Yeon Won, et al.
Publicado: (2014)

Development and testing of a polygenic risk score for breast cancer aggressiveness
por: Shieh, Yiwey, et al.
Publicado: (2023)

Corrole Nanoparticles for Chemotherapy of Castration-Resistant Prostate Cancer and as Sonodynamic Agents for Pancreatic Cancer Treatment
por: Soll, Matan, et al.
Publicado: (2022)

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
por: Plym, Anna, et al.
Publicado: (2021)

A ’compensatory selection’ effect with standardized tests: Lack of correlation between test scores and success is evidence that test scores are predictive of success
por: Huber, David E., et al.
Publicado: (2022)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Keeping score
por: Shannon, Ann
Publicado: (1999)

A Diet Score Assessing Norwegian Adolescents’ Adherence to Dietary Recommendations—Development and Test-Retest Reproducibility of the Score
por: Handeland, Katina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c56c32h21j4dv1aljlhckenbb6